ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 119 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $857,000 | -2.9% | 110,000 | +15.8% | 1.04% | +102.9% |
| Q1 2022 | $883,000 | -41.0% | 95,000 | 0.0% | 0.51% | -48.4% |
| Q4 2021 | $1,497,000 | -20.4% | 95,000 | -9.6% | 1.00% | -27.4% |
| Q3 2021 | $1,881,000 | +65.6% | 105,100 | +43.9% | 1.37% | +74.6% |
| Q2 2021 | $1,136,000 | +688.9% | 73,056 | +630.6% | 0.78% | +946.7% |
| Q1 2021 | $144,000 | -66.5% | 10,000 | -54.3% | 0.08% | -78.9% |
| Q4 2020 | $430,000 | -78.6% | 21,900 | -85.9% | 0.36% | -82.8% |
| Q3 2020 | $2,009,000 | -8.1% | 155,000 | +3.3% | 2.06% | -13.1% |
| Q2 2020 | $2,186,000 | +133.5% | 150,000 | +36.4% | 2.37% | +41.0% |
| Q1 2020 | $936,000 | -35.3% | 110,000 | +25.2% | 1.68% | -30.7% |
| Q4 2019 | $1,447,000 | +70.8% | 87,873 | +46.5% | 2.42% | +185.4% |
| Q3 2019 | $847,000 | +68.4% | 60,000 | +140.0% | 0.85% | +24.7% |
| Q2 2019 | $503,000 | – | 25,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 2,932,865 | $48,304,000 | 3.48% |
| Camber Capital Management LP | 2,950,000 | $48,587,000 | 2.47% |
| Trellus Management Company, LLC | 87,873 | $1,447,000 | 2.42% |
| Redmile Group, LLC | 4,648,570 | $76,562,000 | 1.83% |
| Baupost Group | 8,308,900 | $136,848,000 | 1.51% |
| MAVERICK CAPITAL LTD | 4,958,431 | $81,665,000 | 1.19% |
| Artal Group S.A. | 1,750,000 | $28,823,000 | 1.11% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 175,000 | $2,882,000 | 0.36% |
| 12 West Capital Management LP | 158,700 | $2,614,000 | 0.16% |
| WASATCH ADVISORS LP | 1,101,103 | $18,135,000 | 0.15% |